Cargando…

Correction: Ci et al. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics 2019, 11, 15

Detalles Bibliográficos
Autores principales: Ci, Li-qian, Huang, Zhi-gang, Lv, Feng-mei, Wang, Jun, Feng, Ling-lin, Sun, Feng, Cao, Shui-juan, Liu, Zhe-peng, Liu, Yu, Wei, Gang, Lu, Wei-yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534942/
https://www.ncbi.nlm.nih.gov/pubmed/37765335
http://dx.doi.org/10.3390/pharmaceutics15092188
_version_ 1785112513417838592
author Ci, Li-qian
Huang, Zhi-gang
Lv, Feng-mei
Wang, Jun
Feng, Ling-lin
Sun, Feng
Cao, Shui-juan
Liu, Zhe-peng
Liu, Yu
Wei, Gang
Lu, Wei-yue
author_facet Ci, Li-qian
Huang, Zhi-gang
Lv, Feng-mei
Wang, Jun
Feng, Ling-lin
Sun, Feng
Cao, Shui-juan
Liu, Zhe-peng
Liu, Yu
Wei, Gang
Lu, Wei-yue
author_sort Ci, Li-qian
collection PubMed
description
format Online
Article
Text
id pubmed-10534942
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105349422023-09-29 Correction: Ci et al. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics 2019, 11, 15 Ci, Li-qian Huang, Zhi-gang Lv, Feng-mei Wang, Jun Feng, Ling-lin Sun, Feng Cao, Shui-juan Liu, Zhe-peng Liu, Yu Wei, Gang Lu, Wei-yue Pharmaceutics Correction MDPI 2023-08-24 /pmc/articles/PMC10534942/ /pubmed/37765335 http://dx.doi.org/10.3390/pharmaceutics15092188 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Ci, Li-qian
Huang, Zhi-gang
Lv, Feng-mei
Wang, Jun
Feng, Ling-lin
Sun, Feng
Cao, Shui-juan
Liu, Zhe-peng
Liu, Yu
Wei, Gang
Lu, Wei-yue
Correction: Ci et al. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics 2019, 11, 15
title Correction: Ci et al. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics 2019, 11, 15
title_full Correction: Ci et al. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics 2019, 11, 15
title_fullStr Correction: Ci et al. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics 2019, 11, 15
title_full_unstemmed Correction: Ci et al. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics 2019, 11, 15
title_short Correction: Ci et al. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics 2019, 11, 15
title_sort correction: ci et al. enhanced delivery of imatinib into vaginal mucosa via a new positively charged nanocrystal-loaded in situ hydrogel formulation for treatment of cervical cancer. pharmaceutics 2019, 11, 15
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534942/
https://www.ncbi.nlm.nih.gov/pubmed/37765335
http://dx.doi.org/10.3390/pharmaceutics15092188
work_keys_str_mv AT ciliqian correctioncietalenhanceddeliveryofimatinibintovaginalmucosaviaanewpositivelychargednanocrystalloadedinsituhydrogelformulationfortreatmentofcervicalcancerpharmaceutics20191115
AT huangzhigang correctioncietalenhanceddeliveryofimatinibintovaginalmucosaviaanewpositivelychargednanocrystalloadedinsituhydrogelformulationfortreatmentofcervicalcancerpharmaceutics20191115
AT lvfengmei correctioncietalenhanceddeliveryofimatinibintovaginalmucosaviaanewpositivelychargednanocrystalloadedinsituhydrogelformulationfortreatmentofcervicalcancerpharmaceutics20191115
AT wangjun correctioncietalenhanceddeliveryofimatinibintovaginalmucosaviaanewpositivelychargednanocrystalloadedinsituhydrogelformulationfortreatmentofcervicalcancerpharmaceutics20191115
AT fenglinglin correctioncietalenhanceddeliveryofimatinibintovaginalmucosaviaanewpositivelychargednanocrystalloadedinsituhydrogelformulationfortreatmentofcervicalcancerpharmaceutics20191115
AT sunfeng correctioncietalenhanceddeliveryofimatinibintovaginalmucosaviaanewpositivelychargednanocrystalloadedinsituhydrogelformulationfortreatmentofcervicalcancerpharmaceutics20191115
AT caoshuijuan correctioncietalenhanceddeliveryofimatinibintovaginalmucosaviaanewpositivelychargednanocrystalloadedinsituhydrogelformulationfortreatmentofcervicalcancerpharmaceutics20191115
AT liuzhepeng correctioncietalenhanceddeliveryofimatinibintovaginalmucosaviaanewpositivelychargednanocrystalloadedinsituhydrogelformulationfortreatmentofcervicalcancerpharmaceutics20191115
AT liuyu correctioncietalenhanceddeliveryofimatinibintovaginalmucosaviaanewpositivelychargednanocrystalloadedinsituhydrogelformulationfortreatmentofcervicalcancerpharmaceutics20191115
AT weigang correctioncietalenhanceddeliveryofimatinibintovaginalmucosaviaanewpositivelychargednanocrystalloadedinsituhydrogelformulationfortreatmentofcervicalcancerpharmaceutics20191115
AT luweiyue correctioncietalenhanceddeliveryofimatinibintovaginalmucosaviaanewpositivelychargednanocrystalloadedinsituhydrogelformulationfortreatmentofcervicalcancerpharmaceutics20191115